SAMH
IMGN

Shanda Asset Management Holdings’s Immunogen Inc IMGN Stock Holding History

Shanda Asset Management Holdings’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-115,875
Closed -$533K – 106
2020
Q2 		$533K Buy
+115,875
New +$493K 0.05% 71

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Shanda Asset Management Holdings's IMGN Position: Q3 2020 in Review

Shanda Asset Management Holdings sold out of Immunogen Inc (IMGN) in Q3 2020, closing a stake of 115,875 shares — an estimated $533K sold.

Shanda Asset Management Holdings first reported a position in IMGN in Q2 2020 and held it in 1 quarter. The position peaked at $533K in Q2 2020. 185 funds tracked by Wall St. Rank hold IMGN as of Q3 2020.

  • Shanda Asset Management Holdings reported no remaining Immunogen Inc position as of Q3 2020 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 115,875 Immunogen Inc shares in Q3 2020, an estimated $533K.
  • Shanda Asset Management Holdings first reported a position in Immunogen Inc in Q2 2020 and held it in 1 quarter.
  • Shanda Asset Management Holdings's Immunogen Inc position peaked at $533K in Q2 2020.
  • 185 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2020.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.